why novartis� landmark cancer drug approval is great news for bluebird.

the data also revealed 66% of trusts who replied had at least one cancer patient forced to wait over six months to start treatment, and 69% had a worse longest wait than in 2010..

.

comments https://drbryanpwalsh.com/Castoreno-mother-of-Hibert-from-Patea?Howryson=174

cancer patients� lives at risk due to savage tory nhs cuts causing delays to treatment by 18 months.

.